CELH
Celsius Holdings, Inc.
CELH has the edge over LGCY overall, supported by stronger fundamentals and stronger valuation.
LGCY
Legacy Education Inc.
LGCY has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LGCY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
LGCY's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
LGCY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $8.15 | — |
| Cheap | 15x | $8.49 | +4.2% |
| Current | 15x | $8.15 | — |
| Fair | 18x | $10.35 | +27% |
| Expensive | 20x | $11.21 | +38% |
Historical ranges are pointers, not guarantees.
LGCY has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
LGCY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LGCY, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
LGCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.76 | +36% |
| Q3 2026 | $0.56 | +3.7% |
| Q2 2026 | $0.66 | +12% |
| Q1 2026 | $0.60 | 0% |
| Q4 2025 | $0.59 | +28% |
| Q3 2025 | $0.54 | +35% |
| Q2 2025 | $0.59 | +157% |
| Q1 2025 | $0.60 | +233% |
| Q4 2024 | $0.46 | +229% |
LGCY has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over LGCY on profitability, with a higher operating margin.
LGCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20M | +3.1% |
| Q2 2026 | $20.1M | +12% |
| Q1 2026 | $21.4M | +15% |
| Q4 2025 | $19.2M | +41% |
| Q3 2025 | $19.4M | +39% |
| Q2 2025 | $18M | +41% |
| Q1 2025 | $18.6M | +51% |
| Q4 2024 | $13.6M | +29% |
LGCY's revenue has grown year over year for 12 quarters in a row: $20M last quarter, up 3.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.4% | -9.5 points |
| Q2 2026 | 13% | +1.9 points |
| Q1 2026 | 18% | -1.3 points |
| Q4 2025 | 13% | +1.2 points |
| Q3 2025 | 14% | -5.2 points |
| Q2 2025 | 11% | +4.6 points |
| Q1 2025 | 20% | +0.6 points |
| Q4 2024 | 12% | -3.4 points |
LGCY's operating margin was 4.4% last quarter, down 9.5 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over LGCY on cash flow, with more consistent year-over-year improvement.
LGCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -230% |
| Q2 2026 | $843K | -71% |
| Q1 2026 | $515.8K | -14% |
| Q4 2025 | $512.7K | +9.8% |
| Q3 2025 | $809.7K | -73% |
| Q2 2025 | $2.9M | +$3.9M |
| Q1 2025 | $596.6K | +$910.2K |
| Q4 2024 | $466.8K | -79% |
LGCY usually generates cash, though not every quarter: the latest was −$1M, but it generated $819,115 over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over LGCY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
LGCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +178K shares |
| 1 year | +1.6% | +228K shares |
| 3 years | -49% | -13.7M shares |
| 5 years | -80% | -54.8M shares |
| Available history | -80% | -58M shares |
LGCY has 14M diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2019 | — |
| Q3 2019 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
LGCY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -1.7x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
LGCY has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
LGCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.4 | Neutral |
| Stochastic | 9.3 | Oversold |
LGCY's weekly RSI is 31 (neutral) and its Stochastic is 9 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
LGCY PE vs Consumer Defensive Sector
| Metric | LGCY | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 19x | 25% below |
| PE % | 9 | 23 | 14 pts below |
LGCY has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus LGCY above 0 of 4.
LGCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.50 | 14% below |
| 20 week MA | $10.5 | 22% below |
| 50 week MA | $11.1 | 27% below |
| 100 week MA | $10.2 | 20% below |
LGCY is in a downtrend: it's below all four of its weekly moving averages, and 20% below its 100-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
LGCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.39 | $8.25 | +88% |
| 2025 | $8.25 | $10.5 | +28% |
| 2026 YTD | $10.5 | $8.15 | -23% |
LGCY has the edge over CELH on returns for 2026, with the stronger performance.